Characteristic | Median (IQR) |
---|---|
aCD4 count (cells/mm3) | 520 (300–699) |
Nadir CD4 count (cells/mm3) | 250 (135–430) |
Time since HIV Diagnosis (Months) | 73 (30–113) |
Time since ART Initiation (Months) | 69 (29–107) |
bAdherence Self Report Score | 24.5 (21–25) |
Current ART Regimen | Frequency |
First Line ART regimen | |
 Stavudine/Lamivudine/Nevirapine | 2% |
 Tenofovir/Lamivudine/Nevirapine | 2% |
 Zidovudine/Lamivudine/Nevirapine | 1% |
 Tenofovir/Lamivudine/Efavirenz | 93% |
Second Line ART regimen | |
 Abacavir/Lamivudine/Atazanavir | 2% |
Medication Switched Since Initiation | |
 Yes | 30% |
 No | 70% |